These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18453637)

  • 1. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
    Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL
    Cardiovasc Res; 2008 Jul; 79(2):287-93. PubMed ID: 18453637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
    Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
    Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque.
    Dandapat A; Hu CP; Chen J; Liu Y; Khan JA; Remeo F; Carey RM; Hermonat PL; Mehta JL
    Biochem Biophys Res Commun; 2008 Feb; 366(4):871-7. PubMed ID: 18037370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion.
    Hu C; Dandapat A; Chen J; Fujita Y; Inoue N; Kawase Y; Jishage K; Suzuki H; Sawamura T; Mehta JL
    Cardiovasc Res; 2007 Nov; 76(2):292-302. PubMed ID: 17707356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice.
    Hu C; Chen J; Dandapat A; Fujita Y; Inoue N; Kawase Y; Jishage K; Suzuki H; Li D; Hermonat PL; Sawamura T; Mehta JL
    J Mol Cell Cardiol; 2008 Jan; 44(1):76-83. PubMed ID: 18022184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression.
    Hu C; Dandapat A; Chen J; Liu Y; Hermonat PL; Carey RM; Mehta JL
    Atherosclerosis; 2008 Aug; 199(2):288-94. PubMed ID: 18096165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice.
    Xu X; Gao X; Potter BJ; Cao JM; Zhang C
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):871-7. PubMed ID: 17272755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
    Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
    Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaques.
    He L; Game BA; Nareika A; Garvey WT; Huang Y
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):212-22. PubMed ID: 17110803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR; Moulton KS; Kazlauskas A
    Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOX-1 and atherosclerosis: proof of concept in LOX-1-knockout mice.
    Morawietz H
    Circ Res; 2007 Jun; 100(11):1534-6. PubMed ID: 17556664
    [No Abstract]   [Full Text] [Related]  

  • 16. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
    Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional effects of eggs, naturally enriched with conjugated linoleic acid, on the blood lipid profile, development of atherosclerosis and composition of atherosclerotic plaque in apolipoprotein E and low-density lipoprotein receptor double-knockout mice (apoE/LDLR-/-).
    Franczyk-Zarów M; Kostogrys RB; Szymczyk B; Jawień J; Gajda M; Cichocki T; Wojnar L; Chlopicki S; Pisulewski PM
    Br J Nutr; 2008 Jan; 99(1):49-58. PubMed ID: 17678565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baroreflex sensitivity and oxidative stress in the LDL receptor knockout mice.
    Campos C; Bertagnolli M; Evangelho J; Tusset C; Belló-Klein A; Irigoyen MC; Rigatto K
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):329-35. PubMed ID: 18434114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse.
    Overton CD; Yancey PG; Major AS; Linton MF; Fazio S
    Circ Res; 2007 Mar; 100(5):670-7. PubMed ID: 17303763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.